论文部分内容阅读
冠心病患者经皮冠状动脉介入(PCI)术前后,血浆脑钠尿肽N末端前体(NT-proBNP)浓度的变化,可能对疾病的危险度分层及远期预后有独立的预测价值,有利于指导临床治疗,可望成为新的生化标志物。本文就近年该领域的研究进展进行了综述。
The changes of plasma brain natriuretic peptide N-terminal progenitor (NT-proBNP) concentrations before and after percutaneous coronary intervention (PCI) in coronary heart disease patients may have independent predictive value for the risk stratification and long-term prognosis of the disease , Is conducive to guiding clinical treatment, is expected to become a new biochemical markers. This article summarizes the research progress in this area in recent years.